Latest News
Modeling T Cell Dysfunction: New Frontiers in Immunometabolism
While cancer immunotherapies—particularly immune checkpoint blockades (ICBs)—have transformed clinical oncology, primary and acquired resistance remain major hurdles in solid tumors. Mounting evidence reveals that this non-responsiveness is deeply tied to the...
Latest News
New Research On the Next Phase in Protecting Muscle During GLP-1 Treatment
When I wrote previously for this publication about the gap between GLP-1 prescribing rates and the clinical conversation around lean muscle preservation, the argument centred on a simple premise: weight loss is not fat loss, and the clinical infrastructure around...
Atacicept FDA Approval: Trutakna Cleared for IgAN
The atacicept FDA approval that the nephrology community had been anticipating since January arrived on schedule on 7 July 2026, when the US Food and Drug Administration granted accelerated approval to Vera Therapeutics' atacicept-vymj, to be marketed as Trutakna, for...
AI Trust in Healthcare Starts with the People in the Room
Healthcare is on an accelerated path to digitisation, creating real opportunity to reduce administrative burden, improve risk detection, support prioritisation, and help people access the right care sooner. But without deliberate design, these same systems risk...
The Regulatory Window for AI in Pharmacovigilance Is Open
In more than two decades of working with global CROs, pharmaceutical companies, and biotech organizations, I have watched pharmacovigilance teams absorb wave after wave of increasing complexity. More products on the market. More data sources to monitor. More...
Join The Future Of Life Sciences Media
In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters — all in real time.
Don’t wait for the media to pick up your story. Be the media.
Trending
More News
Biomanufacturing is the Next Industrial Revolution
Across the life sciences sector, a profound shift is underway. Biomanufacturing is poised to become a foundational pillar of how we will make things in the 21st century. Advances in bioreactor design, synthetic biology, and sustainable bioprocessing are enabling...
From Kennels to Clinics: Translating Veterinary Research to Human Trials
The next operational lessons for early-stage clinical trials in humans might not come from pharma but from a cattle ranch in Nebraska. While human clinical research debates decentralized trials, adaptive protocols, novel technologies, and new approaches to oversight,...
Statins Safer Than Previously Thought, Major Review Finds
Cholesterol-lowering drugs known as statins, taken by millions worldwide, are significantly safer than often perceived, according to a major new scientific analysis. Conducted by the Cholesterol Treatment Trialists’ (CTT) Collaboration and published in The Lancet, the...
Emotion-Aware Companion Robotics: Rethinking Aged Care
Ageing at home is widely accepted as the ideal outcome for older adults, families and healthcare systems, but the way we attempt to support it is deeply flawed. Most technologies deployed into homes today are built on a reactive model of care - where they wait for...
Antibiotic Resistance: The Silent Pandemic Undermining Modern Medicine
Antibiotics are one of the greatest success stories in modern medicine. They transformed once-deadly infections into treatable illnesses, made routine surgery possible, and helped extend human life expectancy worldwide. From treating pneumonia to protecting patients...
Food Allergy Risk is Rising Faster Than Our Systems Can Respond
Why Life Sciences and Health Tech Must Rethink Prevention Food allergies represent a growing and under addressed challenge within public health and preventative medicine. While prevalence and severity continue to rise, the systems designed to protect individuals have...
Raising Expectations for Medical Liaisons
In the last decade, the Medical Science Liaison role has evolved from a scientific messenger to a field based strategist operating in one of the most highly scrutinized environments in healthcare. That evolution is why board certification is moving from optional...
Lilly Finalizes “Lilly Lehigh Valley” with $3.5B Manufacturing Hub
Eli Lilly and Company has officially selected Fogelsville, Pennsylvania, as the site for its newest $3.5 billion injectable medicine and device manufacturing facility. Operating under the name "Lilly Lehigh Valley," the project represents the final piece of a quartet...
Why Collagen Has Become the Cornerstone of Modern Aesthetics
Beauty is no longer driven by illusion. The era of exaggerated results and quick fixes is giving way to a more intelligent, informed approach, one that prioritises biology over bravado. At the heart of this shift sits collagen, a once-overlooked structural protein now...
AstraZeneca Commits $15bn to Expand R&D and Manufacturing in China
AstraZeneca has announced plans to invest up to 15 billion US dollars to expand its research, development, and manufacturing operations in China, reinforcing the country’s role as a central pillar of the company’s global strategy. The long-term investment will fund...
Why Hypoxia Workstations are Becoming Standard Lab Infrastructure
“Hypoxia” used to be nothing but a niche biology topic. Today it is quietly becoming standard infrastructure in labs. Two forces are converging. Regulators and funders are nudging R&D away from default animal studies and toward human-relevant evidence. At the...
Our Reliance on Antidepressants: What the Numbers Are Telling Us
Antidepressant use has become a defining feature of modern mental healthcare. In the UK alone, an estimated 8.7 million people are currently taking antidepressant medications, reflecting both the scale of mental health need and the central role pharmacological...
Biomanufacturing is the Next Industrial Revolution
Across the life sciences sector, a profound shift is underway. Biomanufacturing is poised to become a foundational pillar of how we will make things in the 21st century. Advances in bioreactor design, synthetic biology, and sustainable bioprocessing are enabling...
From Kennels to Clinics: Translating Veterinary Research to Human Trials
The next operational lessons for early-stage clinical trials in humans might not come from pharma but from a cattle ranch in Nebraska. While human clinical research debates decentralized trials, adaptive protocols, novel technologies, and new approaches to oversight,...
Statins Safer Than Previously Thought, Major Review Finds
Cholesterol-lowering drugs known as statins, taken by millions worldwide, are significantly safer than often perceived, according to a major new scientific analysis. Conducted by the Cholesterol Treatment Trialists’ (CTT) Collaboration and published in The Lancet, the...
Emotion-Aware Companion Robotics: Rethinking Aged Care
Ageing at home is widely accepted as the ideal outcome for older adults, families and healthcare systems, but the way we attempt to support it is deeply flawed. Most technologies deployed into homes today are built on a reactive model of care - where they wait for...
Antibiotic Resistance: The Silent Pandemic Undermining Modern Medicine
Antibiotics are one of the greatest success stories in modern medicine. They transformed once-deadly infections into treatable illnesses, made routine surgery possible, and helped extend human life expectancy worldwide. From treating pneumonia to protecting patients...
Food Allergy Risk is Rising Faster Than Our Systems Can Respond
Why Life Sciences and Health Tech Must Rethink Prevention Food allergies represent a growing and under addressed challenge within public health and preventative medicine. While prevalence and severity continue to rise, the systems designed to protect individuals have...
Raising Expectations for Medical Liaisons
In the last decade, the Medical Science Liaison role has evolved from a scientific messenger to a field based strategist operating in one of the most highly scrutinized environments in healthcare. That evolution is why board certification is moving from optional...
Lilly Finalizes “Lilly Lehigh Valley” with $3.5B Manufacturing Hub
Eli Lilly and Company has officially selected Fogelsville, Pennsylvania, as the site for its newest $3.5 billion injectable medicine and device manufacturing facility. Operating under the name "Lilly Lehigh Valley," the project represents the final piece of a quartet...
Why Collagen Has Become the Cornerstone of Modern Aesthetics
Beauty is no longer driven by illusion. The era of exaggerated results and quick fixes is giving way to a more intelligent, informed approach, one that prioritises biology over bravado. At the heart of this shift sits collagen, a once-overlooked structural protein now...
AstraZeneca Commits $15bn to Expand R&D and Manufacturing in China
AstraZeneca has announced plans to invest up to 15 billion US dollars to expand its research, development, and manufacturing operations in China, reinforcing the country’s role as a central pillar of the company’s global strategy. The long-term investment will fund...
Why Hypoxia Workstations are Becoming Standard Lab Infrastructure
“Hypoxia” used to be nothing but a niche biology topic. Today it is quietly becoming standard infrastructure in labs. Two forces are converging. Regulators and funders are nudging R&D away from default animal studies and toward human-relevant evidence. At the...
Our Reliance on Antidepressants: What the Numbers Are Telling Us
Antidepressant use has become a defining feature of modern mental healthcare. In the UK alone, an estimated 8.7 million people are currently taking antidepressant medications, reflecting both the scale of mental health need and the central role pharmacological...
Featured Articles
Further News
Phacilitate Unites CGT Community for New Era Defined by Collaboration
Phacilitate announces the return of Advanced Therapies Week (ATW) for its 22nd year, reinforcing its status as one of the most established and influential cell and gene therapy (CGT) conferences in the United States and among the most recognized globally. In...
Natural Product Drug Discovery Returns With New Anti Cancer Insights
Scientists have uncovered how plants produce mitraphylline, a rare natural compound with demonstrated anti cancer properties, shedding new light on the biological machinery behind one of nature’s most complex chemical products. By identifying the key enzymes involved...
Biotech’s Funding Winter is Over, but M&A Will Remain Selective
Biotech is showing early signs of life after a prolonged funding winter, but for many early-stage companies, conditions remain unforgiving. Years of low valuations, high borrowing costs and regulatory uncertainty have reshaped investor behaviour, with capital scarce...
Thousands Benefit From New Treatment for Advanced Prostate Cancer
NICE recommends life-extending daily pill which offers hope for people who cannot take standard treatment. Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today (Friday, 23...
A Career in Life Sciences: Pathways, Possibilities and Support
The life sciences sector sits at the intersection of discovery, technology and human impact. From developing new medicines and diagnostics to advancing environmental sustainability and digital health, careers in life sciences offer the chance to work on problems that...
MRI Study Links Inflammation in Brain Reward Centre to Depression Severity
New research suggests that inflammatory and microstructural changes in a key brain reward region may differ between chronic depression and acute depressive symptoms, offering fresh insight into the biological mechanisms underlying the condition. In a large scale...
‘The World Has Not Yet Learned From the COVID Crisis’ Experts Warn
New research published (22 January 2026) in The Lancet Psychiatry warn that lessons have not been learned from the pandemic when it comes to mental health. The researchers recommend that mental health should be treated as a core consideration when it comes to pandemic...
Recovery as Signal Engineering: How Stress Upgrades Human Physiology
For decades, recovery has been framed as the absence of stress. Rest, relaxation, sleep, and passive modalities have been treated as the antidote to physiological load. While these elements matter, they represent only a fraction of how biological systems actually...
Novo Nordisk and Aspect Biosystems Expand Diabetes Collaboration
Novo Nordisk and Aspect Biosystems expand collaboration to accelerate curative diabetes therapies The landscape of regenerative medicine has shifted significantly following the announcement that Novo Nordisk and Aspect Biosystems are entering a comprehensive new phase...
Why Every Business Leader Should be Assessing Their Brain in 2026
As a business leader, we reflect on so much of our performance but not the thing that's driving it: our brains. Yet it's our brain anatomy which is truly individualised and unique to each business owner. Without it, our business cannot run. As a cognitive health...
GSK Makes $2.2 Billion Bid for RAPT Therapeutics
GSK has agreed to acquire US biotech company RAPT Therapeutics in a deal valued at approximately 2.2 billion US dollars, strengthening its position in immunology and signalling a major push into the emerging food allergy treatment market. The acquisition centres on...
What is the Metabolic Reset Diet – The Science
The science, the promise, and the pitfalls The idea of a “metabolic reset” has gained traction across wellness media, social platforms, and weight management programmes. The premise is appealing: that metabolism can be “retrained” or “rebooted” through short-term...
Further News
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.
Don’t wait for the media to pick up your story. Be the media.
See More Articles
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.